Older women who received denosumab (Prolia, Amgen) for up to 10 years for osteoporosis had a low risk of osteonecrosis of the jaw (ONJ), although the risk was higher — albeit still quite small — if ...

Researchers at Scottish Rite for Children received a $2.3 million, five-year grant from the National Institutes of Health (NIH) to study how the body repairs bone and restores blood flow in ...

A humanized antibody used in cancer immunotherapy may be associated with a 44-year-old woman developing osteonecrosis of the jaw (ONJ). The case report was published on January 1 in Oral Surgery, Oral ...

Osteonecrosis of the jaw (ONJ) is a serious complication for physicians prescribing bone resorption inhibitors to patients with osteoporosis. A session at the recent French Congress of Rheumatology ...

Osteonecrosis of the jaw (ONJ) is a debilitating bone condition that affects the jaws and occurs as a result of reduced local blood supply to the bone. Today, experts released a research report that ...

The use of antiresorptive drugs for tumor-related disorders and oral, but not injectable, corticosteroids were associated with an increased risk for osteonecrosis of the jaw among patients with ...

A Montana jury yesterday awarded $3.2 million to a woman who sued the makers of the bone-strengthening drug Zometa. The verdict could set a precedent for hundreds of similar cases pending against the ...

A landmark study by researchers from the SWOG Cancer Research Network, a cancer clinical trials group funded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), ...

The actions of the commonly prescribed oral bisphosphonates are discussed. The groups of patients most likely to present in primary care with an oral bisphosphonate associated osteonecrosis of the ...